The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole

BACKGROUND: The treatment of bipolar disorder (BD) remains a challenge due to the complexity of the disease. Current guidelines represent an effort to assist clinicians in routine practice but have several limitations, particularly concerning long-term treatment. The ARIQUELI (efficacy and tolerabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Missio, Giovani, Moreno, Doris Hupfeld, Fernandes, Fernando, Bio, Danielle Soares, Soeiro-de-Souza, Márcio Gehardt, Rodrigues dos Santos, Domingos, David, Denise Petresco, Costa, Luis Felipe, Demétrio, Frederico Navas, Moreno, Ricardo Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706295/
https://www.ncbi.nlm.nih.gov/pubmed/23805994
http://dx.doi.org/10.1186/1745-6215-14-190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706295/
https://www.ncbi.nlm.nih.gov/pubmed/23805994
http://dx.doi.org/10.1186/1745-6215-14-190

Ejemplares similares